Shijiazhuang Yiling Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 11.60%

Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has an Asset Resilience Ratio of 11.60% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Shijiazhuang Yiling Pharmaceutical Co Lt PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.65 Billion

≈ $240.75 Million USD Cash + Short-term Investments

Total Assets

CN¥14.18 Billion

≈ $2.07 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See how leveraged is Shijiazhuang Yiling Pharmaceutical Co Lt's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Shijiazhuang Yiling Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002603 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.65 Billion	11.6%
Total Liquid Assets	CN¥1.65 Billion	11.60%

Asset Resilience Insights

Moderate Liquidity: Shijiazhuang Yiling Pharmaceutical Co Ltd has 11.60% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Shijiazhuang Yiling Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shijiazhuang Yiling Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Chongqing Taiji Industry Group Co Ltd SHG:600129	Drug Manufacturers - Specialty & Generic	0.47%

Annual Asset Resilience Ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Shijiazhuang Yiling Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.59%	CN¥764.42 Million ≈ $111.86 Million	CN¥13.67 Billion ≈ $2.00 Billion	+4.38pp
2023-12-31	1.21%	CN¥205.97 Million ≈ $30.14 Million	CN¥16.98 Billion ≈ $2.48 Billion	-1.96pp
2022-12-31	3.17%	CN¥518.38 Million ≈ $75.86 Million	CN¥16.34 Billion ≈ $2.39 Billion	+2.74pp
2021-12-31	0.43%	CN¥55.27 Million ≈ $8.09 Million	CN¥12.90 Billion ≈ $1.89 Billion	-1.46pp
2020-12-31	1.89%	CN¥216.97 Million ≈ $31.75 Million	CN¥11.51 Billion ≈ $1.68 Billion	-1.34pp
2019-12-31	3.23%	CN¥292.73 Million ≈ $42.84 Million	CN¥9.07 Billion ≈ $1.33 Billion	-5.03pp
2018-12-31	8.26%	CN¥706.72 Million ≈ $103.42 Million	CN¥8.56 Billion ≈ $1.25 Billion	-2.69pp
2017-12-31	10.95%	CN¥863.39 Million ≈ $126.34 Million	CN¥7.89 Billion ≈ $1.15 Billion	+9.37pp
2016-12-31	1.58%	CN¥98.94 Million ≈ $14.48 Million	CN¥6.26 Billion ≈ $915.73 Million	+1.00pp
2015-12-31	0.58%	CN¥33.37 Million ≈ $4.88 Million	CN¥5.71 Billion ≈ $835.11 Million	-7.33pp
2014-12-31	7.92%	CN¥402.81 Million ≈ $58.94 Million	CN¥5.09 Billion ≈ $744.52 Million	-2.39pp
2013-12-31	10.30%	CN¥480.00 Million ≈ $70.24 Million	CN¥4.66 Billion ≈ $681.62 Million	--

pp = percentage points

About Shijiazhuang Yiling Pharmaceutical Co Ltd

SHE:002603 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.67 Billion

CN¥25.09 Billion CNY

Market Cap Rank

#4411 Global

#746 in China

Share Price

CN¥15.02

Change (1 day)

+0.47%

52-Week Range

CN¥13.91 - CN¥21.05

All Time High

CN¥1254.44